Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
fever blister; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of fever blister in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. The patient's past medical history included fever blister. Previously administered products included Shingles vaccine (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of Shingles vaccine. In MAR-2025, an unknown time after receiving Shingles vaccine, the patient experienced fever blister (Verbatim: fever blister). The outcome of the fever blister was not reported. It was unknown if the reporter considered the fever blister to be related to Shingles vaccine. It was unknown if the company considered the fever blister to be related to Shingles vaccine. Additional Information: GSK receipt date: 05-APR-2025 This case was reported by a patient via interactive digital media. The patient had both shots and it was easy. The patient had a fever blister last week and it was different from past ones.
Medical History/Concurrent Conditions: Fever blister